
Dr Robin Corey
BSc, MSc, PhD
Expertise
Computational biophysicist/pharmacologist at the University of Bristol | GPCRs | Ion channels | Molecular dynamics | Molecular modelling | Free energy calculations | Python | Coarse-grained simulations
Current positions
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
I studied Biochemistry at the University of York, before moving to Bristol to carry out a PhD in Bristol. Here I used experimental techniques and molecular modelling to help undestand protein secretion in bacteria as a part od Ian Collinson's lab.
Following this, I moved to the University of Oxford to work with Mark Sansom and Phill Stansfeld for a 5 year PDRA to consolidate my molecular modelling expertise. This includes developing specialized tools and protocols for molecular modelling of membrane proteins.
I joined the School of Physiology, Pharmacology, and Neuroscience in July 2023 as a lecturer. Here I research and teach on understanding the biology and pharmacology of membranes proteins such as GPCRs and ion channels using molecular modelling and AI.
Following this, I moved to the University of Oxford to work with Mark Sansom and Phill Stansfeld for a 5 year PDRA to consolidate my molecular modelling expertise. This includes developing specialized tools and protocols for molecular modelling of membrane proteins.
I joined the School of Physiology, Pharmacology, and Neuroscience in July 2023 as a lecturer. Here I research and teach on understanding the biology and pharmacology of membranes proteins such as GPCRs and ion channels using molecular modelling and AI.
Publications
Recent publications
14/01/2026Insights from aquaporin structures into drug-resistant sleeping sickness
eLife
In silico discovery and characterisation of a novel nuclear transcription factor-Y (NF-Y) inhibitor with anti-mitogenic properties
Journal of Medicinal Chemistry
Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization
eLife
Noncanonical pharmacological inhibition of the hERG K+ channel by a synthetic cannabinoid
Biochemical Pharmacology
Structural snapshots of Pseudomonas aeruginosa LptB2FG and LptB2FGC reveal insights into lipopolysaccharide recognition and transport
Nature Communications
